SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 771.48+1.2%Jan 27 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (77)4/10/1997 2:29:00 PM
From: F. Jay Abella, III   of 3559
 
MZ -

I have been reading the board and studying the content of the messages
in relation to the timing of actual events. I find it amazing that
after what happened in January that anyone holds (or even discusses)
this stock at all. As an objective observer, I am wondering heavily
if the management did in fact leak negative information to an
influential holder of stock prior to the announcement. Coupled with
the wording of the original P&G press release and information cited
in the 10Q, I think doom was utterly predictable.
But then again, hindsight is 20-20.

FJA

PS - You do realize that at the same time REGN was telling the world that
the BDNF product didn't work, that one of the scientists spearheading
the program was discussing the merits of the product at BioEast?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News